LICENSE TO PUBLISHMarch 2nd, 2022
FiledMarch 2nd, 2022With the submission of a manuscript to NeuroImmune Pharmacology and Therapeutics (“Journal”), Society on NeuroImmune Pharmacology (“Journal Owner”), Walter de Gruyter GmbH (“Publisher”), all authors indicate that they agree to the submission of the manuscript and the correctness of the content and that they understand and will abide the following Lincense to Publish.
LICENSE TO PUBLISHJanuary 20th, 2022
FiledJanuary 20th, 2022With the submission of a manuscript to Online Media and Global Communication (“Journal”), Shanghai International Studies University (“Journal Owner”), Walter de Gruyter GmbH (“Publisher”), all authors indicate that they agree to the submission of the manuscript and the correctness of the content and that they understand and will abide the following Lincense to Publish.
LICENSE TO PUBLISHJanuary 20th, 2022
FiledJanuary 20th, 2022With the submission of a manuscript to Eastern European Holocaust Studies (“Journal”), Charity Organization “Babyn Yar Holocaust Memorial Charity Fund” (“Journal Owner”), Walter de Gruyter GmbH (“Publisher”), all authors indicate that they agree to the submission of the manuscript and the correctness of the content and that they understand and will abide the following Lincense to Publish.